Industry executives and experts share their predictions for 2025. Read them in this 17th annual VMblog.com series exclusive.
By Eric Demers, CEO, Madaket
Health
In
2025, healthcare, and the world, will see AI slip further into Gartner's "Trough of
Disillusionment." When progress can't keep pace with hype, expectations turn
into frustrations. Advancements are being made. However, they aren't the
head-turning, flip-a-switch, and watch-the-results-pour-in examples many
envisioned and extolled. And in healthcare, which is typically wary about
adopting new technology, developments will come even slower.
Slow but steady success
Businesses
worldwide are in a mad dash to claim they have AI under the hood. The truth is,
few do, and in healthcare, the number is even smaller - but no one wants to
seem like a laggard. Greater use cases will emerge in mainstream business,
putting earlier adopters in a good position to capitalize by year's end.
Healthcare, however, will see just a trickle of successful implementations, but
they will steadily increase over time.
Further,
because healthcare in the U.S. is so complex, it will take AI tools a while to
accumulate the necessary data and come up to speed. In 2025, healthcare will
see improved access to data to feed the "AI machine" properly, which will then
open the technology up to meaningful applications that produce impactful
results.
Too rich for our blood
AI
research and implementation is very expensive and time-consuming. Institutions
with vast resources - technical, operational, and financial - will be the only
ones in healthcare able to afford a seat at that table. But these large medical
centers and health systems will investigate true, AI-powered solutions, and get
results. Mayo Clinic, for instance, is turning AI on its historical lab results for minable
data that could impact the future of healthcare.
While
the examples may be fewer than in other industries, healthcare will see some
strong applications that illustrate how AI can help produce better health and
financial outcomes.
The data do-over
Significant
improvements in data quality are needed for training AI algorithms. There
currently exists siloed data, gaps in data, outdated and dirty data - bad data
is everywhere. Across industries, even in healthcare, this topic is gaining
momentum. Analyst firms are mobilizing and establishing research swimlanes on
the issue. With healthcare realizing how bad data impacts both quality of care
and revenue, we'll see a growing data do-over to nail down this disruptive
issue, once and for all.
Time to align
There
are significant challenges with data alignment between payers (insurers) and
healthcare providers. Much of the process is still done manually and in
disparate ways, ranging from fragmented versions of data intake forms shared
via email to faxes and even phoned-in records. Its estimated provider
directories are about 50% accurate, which makes it difficult for patient care
to go through the system as intended.
Payers
and providers must be in sync so patients get the care they need. This means
using tech to ensure they're at the right place at the right time, and that
costs are as expected. Payers are trying an "innovative approach" that
streamlines spreadsheets. This is antiquated. There already exists advanced
data management and exchange tools for automation and ongoing, real-time
provider data updates. AI is already being used here, too.
The
time to align is long overdue and it's here that we'll see healthcare make real
progress in 2025.
##
ABOUT THE
AUTHOR
Eric Demers is the CEO of Madaket Health. He
believes we can transform healthcare delivery through the power of data and
interoperability. With more than 25 years of global healthcare experience, Eric
has built and scaled leading technology and service companies, from early stage
to Fortune 100. He is highly sought-after for speaking and consulting on
international health, having advised global entities and governments on
critical issues facing healthcare. A growth-minded leader, Eric has founded
three companies and exited two. Eric previously served in strategy-focused
executive roles at IBM, Accreon, MEDecision and Orion Health. He is a
graduate of Brandeis University and The George Washington University School of
Medicine and Health Sciences.